Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Revenue

    Back to Income Statement
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹9,151 Cr₹8,171 Cr₹7,082 Cr₹6,559 Cr₹6,315 Cr

What is the latest Revenue of PIRAMAL PHARMA ?

The latest Revenue ratio of PIRAMAL PHARMA is ₹9,151 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹9,151 Cr
Mar2024₹8,171 Cr
Mar2023₹7,082 Cr
Mar2022₹6,559 Cr
Mar2021₹6,315 Cr

How is Revenue of PIRAMAL PHARMA Trending?

Years Revenue % Change
Mar2025 ₹9,151 Cr
11.99
Mar2024 ₹8,171 Cr
15.39
Mar2023 ₹7,082 Cr
7.97
Mar2022 ₹6,559 Cr
3.87
Mar2021 ₹6,315 Cr -

Compare Revenue of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,320.4 Cr -2.4% 2.4% -11.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-2.4%

2.4%

-11.9%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses